申请人:Shanghai Yao Yuan Biotechnology Co., Ltd.
公开号:US20220177510A1
公开(公告)日:2022-06-09
The disclosure provides compounds, compositions and methods related to activating alpha-kinase 1 (ALPK1) for modulating an immune response and treating or preventing cancer, infection, inflammation and related diseases and disorders as well as potentiating an immune response to a target antigen. The disclosure also provides heterocyclic compounds of formula (I) as agonists of alpha protein kinase 1 (ALPK1) and their use in activating ALPK1, modulating an immune response and treating diseases such as cancer, wherein A
1
, A
2
, L
1
, L
2
, L
3
, Z
1
, Z
2
, W
1
, W
2
, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
and R
7
are as defined herein.